Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 7101-7110 Newer>

Pharmaceutical Executive January 1, 2011 Singh & Glozman	Managing Clinical Trials in Emerging Markets Amgen's hub-and-spoke system combines control at home with the flexibility to respond to local needs.
Pharmaceutical Executive January 1, 2011	The San Diego Story San DIego works as a locus for risky investments in the big ideas that lead to biotech breakthroughs
Pharmaceutical Executive January 1, 2011	The Steep, Slow Climb A survey of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade.
Pharmaceutical Executive January 1, 2011 William Looney	The Night Stalkers "Tops in Fraud" is a ruinous moniker for pharma -- a business so dependent on basic issues of trust, integrity, and quality.
Pharmaceutical Executive January 1, 2011 Roger L. Williams	Ensuring Drug Quality: A Complex Task in a Globalized Era With increasing globalization and longer and more complicated manufacturing supply chains, the quality and safety of our medicines is at much higher risk today than it was a decade ago.
Pharmaceutical Executive January 1, 2011 Walter Armstrong	The List It's a new year. Even pharma, with its glacial timelines, has its "Out with the old, in with the new" moment. Welcome to 2011!
Pharmaceutical Executive January 1, 2011 Eric Boothe	The Right Mix for 2011 Incorporating the proper blend of media into your marketing initiatives will help to increase the flexibility and success of your pharma marketing campaigns.
Pharmaceutical Executive January 1, 2011 Jill Wechsler	Politics & PDUFA Pharma companies will assess health reform, negotiate user fees and keep an eye on federal prosecutors in the year ahead.
The Motley Fool January 24, 2011 Selena Maranjian	Make Money in Medical Devices the Easy Way Get instant exposure to diversification and possible profits.
The Motley Fool January 24, 2011 Seth Jayson	Here's How SuperGen Is Making You So Much Cash With questionable cash flows amounting to only 8.3% of operating cash flow, SuperGen's cash flows look clean.
<Older 7101-7110 Newer> Return to current articles.